Answers are grounded in this paper and cite their sources.
The synthesis and antiplasmodial and antimycobacterial evaluation of two new series of nitroimidazole and nitroimidazooxazine derivatives is described. The majority of these compounds, especially hybrids 9d, 9f, and 14b, exhibited potent activity against the chloroquine-resistant K1 strain of Plasmodium falciparum. Furthermore, a notable number from the tetrazole series were significantly more active against M. tuberculosis than kanamycin, a standard TB drug.
No takes yet. Share an insight, caveat, or question.
Tukulula et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: